AIMDライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications...

Stats
本日の出来高	6 737.00
平均出来高	1.37M
時価総額	6.19M
EPS	$0 ( 2024-03-29 )
次の収益日	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.310
ATR14	$0.00700 (0.67%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-18	Lee Hsin-liang Christopher	Buy	0
2024-02-16	Lee Ting-chuan	Sell	14 400	RSU
2024-02-16	Lee Ting-chuan	Buy	14 400	CommonStock
2024-02-16	Sung Meng Lin	Buy	1 050	Common Stock
2024-02-16	Sung Meng Lin	Sell	1 050	RSU

INSIDER POWER
23.63
Last 95 transactions
Buy: 22 138 064 \| Sell: 12 377 869

Ainos, Inc. 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Ainos, Inc. 財務諸表

Annual	2023
収益:	$122 112
総利益:	$-5.11M (-4 181.56 %)
EPS:	$-3.36

FY	2023
収益:	$122 112
総利益:	$-5.11M (-4 181.56 %)
EPS:	$-3.36

FY	2022
収益:	$3.52M
総利益:	$1.41M (39.93 %)
EPS:	$-5.15

FY	2021
収益:	$594 563
総利益:	$410 382 (69.02 %)
EPS:	$-0.0300

Financial Reports:

No articles found.

Ainos, Inc.

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.